JP Morgan's double upgrade with a 22% PT hike, just 3 days before earnings, is a strong bullish catalyst. With institutional buying accelerating and short interest elevated, AXP could see a squeeze if earnings deliver. Traders should watch for a break above $360 (near the mean target) as confirmation.
Price Chart
Executive Summary
JP Morgan double upgraded AXP from Neutral to Overweight on July 13, 2026, raising the price target to $400 from $328, implying 14.1% upside from the current $350.58. The firm's 56% accuracy on 9 AXP calls and 9.5% average return rank it above average among covering analysts. Consensus is mixed: 18 Buy/Strong Buy (42%), 17 Hold (40%), 1 Sell (2%) from 36 analysts. The mean target is $371.38, median $370, with a high of $450 and low of $312. JP Morgan's new $400 target sits above the mean and median, signaling conviction. Momentum is positive with 2 upgrades and 0 downgrades in the past 30 days, though EPS revisions are slightly negative (3 up vs 5 down for the current quarter). A single insider sale of $2.4M on June 15 is a weak bearish signal, while a congressional buy in May is a minor bullish tick. Institutional buying is strong, with several funds adding or doubling positions. Short interest at 65.3% of TRF volume is elevated, suggesting potential squeeze fuel. The next earnings report is due July 16, just 3 days after this upgrade, adding timing significance. Bottom line: a high-conviction double upgrade from a 56%-accurate firm with a 9.5% average return, above-consensus PT, and strong institutional support — bullish for AXP near-term.
Impact Score
Consensus & Targets
Consensus is mixed: 5 Strong Buy, 13 Buy (42% bullish), 17 Hold (40% neutral), 0 Sell, 1 Strong Sell (2% bearish) from 36 analysts. The consensus leans slightly bullish but with a large neutral camp, making JP Morgan's double upgrade a notable contrarian push toward the bullish side.
Current price: $350.58. Mean target: $371.38, median: $370. High: $450, low: $312. Implied upside to mean: 5.9%. JP Morgan's $400 target is 7.7% above the mean and 8.1% above the median, placing it in the top quartile of analyst targets. The prior PT of $328 was below the mean; the new PT signals a significant re-rating.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-13 | JP Morgan | upgrade | Overweight | $400.00 |
| 2026-07-09 | B of A Securities | maintain | Buy | $391.00 |
| 2026-07-07 | TD Cowen | maintain | Hold | $338.00 |
| 2026-07-07 | UBS | maintain | Neutral | $386.00 |
| 2026-07-07 | Barclays | maintain | Equal-Weight | $364.00 |
| 2026-07-06 | Evercore ISI Group | maintain | In-Line | $380.00 |
| 2026-06-30 | Piper Sandler | initiate | Overweight | $396.00 |
| 2026-06-30 | BTIG | maintain | Sell | $324.00 |
| 2026-06-24 | Truist Securities | maintain | Buy | $375.00 |
| 2026-06-16 | BTIG | reiterate | Sell | $285.00 |
30-day analyst activity: 2 upgrades (JP Morgan double upgrade, Piper Sandler initiate Overweight), 0 downgrades. EPS revisions are mixed: current quarter has 3 upward revisions vs 5 downward in the past 30 days, but the current EPS estimate of $4.40498 is slightly above the 30-day-ago estimate of $4.38435. Full-year 0y estimates show 4 up vs 4 down revisions, with the current estimate of $17.74912 above the 30-day-ago $17.68787. Overall, estimates are stabilizing with a slight upward bias.
Firm Track Record — JP Morgan
JP Morgan accuracy: 55% on 5701 calls | avg return: 5.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| TD Cowen | 100% | 2/2 | 11.5% | top tier |
| Goldman Sachs | 100% | 2/2 | 11.9% | top tier |
| Deutsche Bank | 100% | 2/2 | 11.5% | top tier |
| Barclays | 86% | 6/7 | 10.4% | top tier |
| Evercore ISI Group | 83% | 5/6 | 4.7% | top tier |
| Monness, Crespi, Hardt | 80% | 4/5 | 9.6% | top tier |
| Citigroup | 75% | 3/4 | 0.7% | top tier |
| Truist Securities | 75% | 6/8 | 6.2% | top tier |
| B of A Securities | 71% | 5/7 | 13% | top tier |
| RBC Capital | 71% | 5/7 | 6.4% | top tier |
JP Morgan has 56% accuracy on 9 AXP calls with a 9.5% average return, ranking above average among covering firms. The best-performing firms on AXP are TD Cowen, Goldman Sachs, and Deutsche Bank (all 100% on 2 calls each). The worst are UBS and Keefe, Bruyette & Woods (50% on 2 and 6 calls, respectively). JP Morgan's track record is solid but not elite, making this double upgrade a meaningful but not top-tier signal.
Earnings Estimates
Next earnings: Jul 16, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $4.40 | $4.18 — $4.70 | $19.7B | ↑3 ↓0 |
| +1q | $4.69 | $4.43 — $5.64 | $20.1B | ↑1 ↓0 |
| 0y | $17.75 | $17.04 — $18.71 | $79.5B | ↑3 ↓0 |
| +1y | $20.15 | $19.30 — $20.88 | $86.5B | ↑2 ↓0 |
Cross-Platform Signals
Insider activity: one SELL by McNeal Glenda G on June 15 for $2.4M — a weak bearish signal per academic literature (insider sales are often liquidity-driven). Congressional activity: one buy by Rep. Rick Allen (R) on May 8 for $1K-$15K — a minor bullish tick. Institutional changes are strongly bullish: 5 funds added or doubled positions, including ABN AMRO (+1,384%), Empowered Funds (+189%), and Integrated Wealth Concepts (+79%). Short interest is elevated at 65.3% of TRF volume, suggesting potential squeeze risk. The analyst signal converges with institutional buying and diverges from the insider sale (which is weak). Overall, cross-platform signals are bullish.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $324.43 $305.07 | ▼ −5.97% | ▼ −8.09% | $302.78 (−6.67%) |
Sep 14, 2026 18d ago | Court Ruling | $327.78 $313.59 | ▼ −4.33% | ▼ −4.44% | $302.78 (−7.63%) |
Sep 8, 2026 24d ago | Court Ruling | $326.10 $324.43 | ▼ −0.51% | ▲ +0.61% | $302.78 (−7.15%) |
Aug 19, 2026 6w ago | Court Ruling | $339.90 $336.15 | ▲ +1.10% | ▲ +0.72% | $302.78 (+10.92%) |
Aug 17, 2026 6w ago | 8-K | $336.21 $337.33 | ▲ +0.33% | ▲ +1.52% | $302.78 (−9.94%) |
Aug 13, 2026 7w ago | Institutional Cluster | $343.65 $331.15 | ▼ −3.64% | ▼ −1.67% | $302.78 (−11.89%) |
Aug 5, 2026 8w ago | 8-K | $348.99 $344.08 | ▼ −1.41% | ▼ −1.76% | $302.78 (−13.24%) |
Jul 24, 2026 10w ago | 8-K | $326.17 $337.52 | ▲ +3.48% | ▲ +3.11% | $302.78 (−7.17%) |
Jul 15, 2026 11w ago | 8-K | $358.44 $348.74 | ▼ −2.71% | ▼ −1.73% | $302.78 (−15.53%) |
Jul 15, 2026 11w ago | Court Ruling | $358.44 $348.74 | ▼ −2.71% | ▼ −1.73% | $302.78 (−15.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access